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Abstract
Analysis of multiplexed assays is highly important for clinical diagnostics and other analytical 
applications. Mass cytometry enables multi-dimensional, single-cell analysis of cell type and state. 
In mass cytometry, the rare earth metals used as reporters on antibodies allow determination of 
marker expression in individual cells. Barcode-based bioassays for CyTOF are able to encode and 
decode for different experimental conditions or samples within the same experiment, facilitating 
progress in producing straightforward and consistent results. Herein, an integrated protocol for 
automated sample preparation for barcoding used in conjunction with mass cytometry for clinical 
bioanalysis samples is described; we offer results of our work with barcoding protocol 
optimization. In addition, we present some points to be considered in order to minimize the 
variability of quantitative mass cytometry measurements. For example, we discuss the importance 
of having multiple populations during titration of the antibodies and effect of storage and shipping 
of labelled samples on the stability of staining for purposes of CyTOF analysis. Data quality is not 
affected when labelled samples are stored either frozen or at 4 °C and used within 10 days; we 
observed that cell loss is greater if cells are washed with deionized water prior to shipment or are 
shipped in lower concentration. Once the labelled samples for CyTOF are suspended in deionized 
water, the analysis should be performed expeditiously, preferably within the first hour. Damage 
can be minimized if the cells are resuspended in phosphate-buffered saline (PBS) rather than 
deionized water while waiting for data acquisition.
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Introduction
Cytometry by Time-Of-Flight (CyTOF)
Cytometry by Time-Of-Flight (CyTOF or mass cytometry) is a relatively new and promising 
technology for real-time analysis of single cells using inductively coupled plasma time-of-
flight mass spectrometry [1–8]. Researchers from a variety of disciplines, such as cancer 
research, cardiovascular research, embryonic stem cells and development, gene expression 
profiling, hematopoietic stem cells and progenitors, immunity/infectious disease, induced 
pluripotent stem cells, neural research, and RNA sequencing are expressing strong interest in 
single-cell experimentation methods [9–13]. Mass cytometry provides an important tool for 
single-cell biology and is currently being incorporated into studies in many medical fields 
including immunology, hematology, and oncology; while research in drug companies is 
focused on the mechanism of drug-target interactions and its resulting pharmacology, 
CyTOF allows a deeper analysis of cell phenotypes as compared to flow cytometry [1–6]. 
For example, CyTOF provides the ability to phenotypically and functionally profile cells 
from normal and diseased states. Single-cell technologies have allowed researchers to 
measure the effects of a drug at the single-cell level and better understand its mechanism of 
action.
The current system mass resolving power is between 400 and 600 and defined as R = M/
ΔM, where M designates the mass (TOF at 159 Tb) and ΔM is the full width at half 
maximum (2×FWHM) at the concentration of Tb of 0.5 ppb. There is a trade-off between 
resolution and sensitivity; as resolution is increased the sensitivity decreases so a 
compromise often must be sought. It is important for CyTOF analysis to have optimum 
resolution. CyTOF resolves and detects multiple metal conjugated probes per cell with 
minimal signal overlap, which maximizes the information obtained from each individual 
sample. The CyTOF instrument allows the detection of more than 40 parameters at the 
single-cell level; this capacity will increase as more isotopes become available. Recent 
innovations in CyTOF bring the capability for the simultaneous detection of a major, and 
steadily growing, number of proteins at the single-cell level and facilitate greater 
understanding of both cell phenotype and function.
The importance of automated sample preparation for barcoding technique cannot be 
overstated. Careful sample preparation/cleanup is essential because it can affect the analyte 
ionization on mass spectrometry and subsequently the concentration of the analyte. The 
analytical techniques cannot correct problems generated by sample preparation errors. It is 
important to note that optimization protocols based on each application are necessary 
because no one protocol can fit all applications. Herein, in addition to automated sample 
preparation for barcoding, we will address other sources of variability in mass cytometry 
such as shipping and storage of labelled samples with stable heavy metal isotopes for 
CyTOF analysis, as well as the stability of staining in deionized water as a critical step in the 
analysis.
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Experimental
Apparatus
Mass cytometry—Mass cytometry measurements were performed on a CyTOF 2 
instrument (Fluidigm, Sunnyvale, CA). The CyTOF 2 instrument was started, tuned, and 
cleaned as per manufacturer’s instructions (Fluidigm, Sunnyvale, CA) [14]. Samples were 
injected into the sample loop in portions of 500 µl and run for 10 min at flow rate 45 µl/min. 
Cells were injected as a single-cell suspension in water supplemented with EQ™ Four 
element calibration beads (Fluidigm, Sunnyvale, CA) after filtration through a 35-µm nylon 
mesh (cell strainer cap tubes, BD, San Jose, CA) immediately prior to acquisition. 
Calibration bead signals were used to monitor the detector performance over the runtime. 
Before sample loading, QC was performed based on collecting information of the automated 
tuning procedure and data from EQ™ Four element calibration beads (Fluidigm), and 
successfully passed for all experiments. Data were acquired in Dual data calibration mode, 
with noise reduction turned off and lower and upper cell length parameter values set to 10 
and 150, respectively. FCS files were generated by CyTOF instrument control software 
v6.0.622 (Fluidigm), which also served to control the instrument. The normalization 
software is based on the concept of a Bead Passport. The Bead Passport is a global standard 
generated by the manufacturer for a specific lot of EQ beads. This Passport is universal 
across all instruments of the same type and cannot be changed by individual users. Using a 
global standard allows normalization of data within and across experiments as well as across 
instruments [14].
Materials and human subjects—Ir-intercalator stock solution 125 M cat # 201192A, 
metal conjugated antibodies and Cell-ID™ 20-Plex Pd Barcoding Kit cat #201060, EQ™ 
Four Element Calibration Beads contain natural abundance cerium (140/142Ce), europium 
(151/153Eu), holmium (165Ho), and lutetium (175/176Lu), Catalog#: 201078 were obtained 
from (Fluidigm, Sunnyvale, CA), cisplatin cat # 15663-27-1 and RPMI-1640, cat # R0883 
(Sigma-Aldrich, St. Louis, MO), and Foxp3 / Transcription Factor Staining Buffer Set cat # 
00-5523-00 (eBioscience, Inc. San Diego, CA), BD GolgiStop™ (BD Biosciences, catalog 
number: 554715). For human subjects, heparinized blood from healthy volunteers was 
obtained after written informed consent under the guidelines and approval of the Human 
Investigations Committee of Yale University School of Medicine. Donors had no acute 
illness and took no antibiotics or non-steroidal anti-inflammatory drugs within 1 month of 
enrollment.
Sample preparation using barcoding for CyTOF
Sample collection, preparation, and storage—Fresh blood was collected and placed 
on lithium heparin; after PBMC isolation cells were washed in x-vivo medium, counted and 
the concentration adjusted to 10 million/ml (2 million cells total). One-half (1 million) of the 
cells were incubated with GolgiStop alone. The other half was incubated with GolgiStop and 
PMA + ionomycin (250/50 ng/ml) for 4 h. After 4 h cells were washed twice with PBS 
(centrifuged at 1000×g for 4 min) and incubated for 1 min with a solution of cis-
Diammineplatinum(II) dichloride (cisPt, Sigma-Aldrich, CAS Number 15663-27-1, St. 
Louis, MO 63103) 150 µl/sample (50 µM, 1 min). Incubation with cisPt was stopped by 
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adding equal volume of staining buffer (SB) containing BSA and centrifugation at 350×g 5 
min. The cell pellet was resuspended in 300 µl SB and the washing step was repeated twice. 
Samples were immediately fixed in 200 µl fixation buffer, FB (Foxp3/Transcription Factor 
Staining Buffer Set eBioscience, Inc. San Diego, CA cat # 00-5523-00) and stored at −80 °C 
until use (up to 18 months).
Cell staining for CyTOF mass spectrometry—Samples were processed in batches of 
20 samples using an automated Biomek robotic platform (Beckman Coulter) for cell 
barcoding and labeling for CyTOF analysis. Samples were transferred from −80 °C to a 
hood and allowed to thaw slowly on ice. Two volumes of PBS were added to each sample, 
then centrifuged for 4 min at 1000×g. The pellet was resuspended in 250 µl of PBS, and the 
20 samples were transferred to two 10 rows of a V bottom 96 well plate. The plate was 
centrifuged at 1000×g for 4 min, supernatant discarded and the pellet resuspended in 250 µl 
of PBS. This step was repeated twice. Five microliters of Fc block was added to each well 
followed by adding 25 µl of a cocktail of metal conjugated antibodies for the following 
surface markers (CXCR3, CCR4, CXCR5, CCR6, CCR7, CD45RO, CD127 obtained from 
Fluidigm, Sunnyvale, CA) in SB; this mixture was incubated before barcoding for 30 min. 
Two hundred twenty-five microliters of SB was added to each well. The plate was 
centrifuged at 1000×g, the supernatants removed, and samples were washed once with 250 
µl of MCB (mass-tag cellular barcoding, Fluidigm, Sunnyvale, CA) permeabilization buffer. 
The pellet was resuspended in 200 µl of MCB permeabilization buffer (PB). 100× 
combinatorial MCB tubes (20 uL) were thawed as needed (2 rows of tubes for 20 samples of 
barcodes 1 to 20) at 37 °C. Then, 100 µl of PB was added to each MCB tube and mixed. 30 
µl of MCB were transferred to each well followed by mixing well with the samples and 
incubation at RT for 30 min. The remaining MCB tubes were capped and stored for up to 1 
week at 4 °C. The samples were centrifuged and washed three times with 250 µl SB, then 
the 20 samples were combined in one eppendorf tube by successively washing all the wells 
with 200 µl SB four times.
The barcoded samples were counted using Guava cell counter (up to 10 million cells), 
resuspended in 100 µl of the cocktail mixture of metal conjugated antibodies of interest and 
incubated for 30 min at room temperature. At the end of the incubation, 900 µl of SB were 
added to the samples and centrifuged at 1000×g for 4 min. The samples were washed once 
with 1 mL FB, then incubated overnight at 4 °C with 1 ml of FB containing 1 µl/ml of 191 
and 193 Iridium DNA intercalator. Samples were washed twice with 1 ml PBS, then the 
cells were counted. Cells were washed with 500 µL deionized water, then centrifuged at 
800×g for 10 min at 4 °C and supernatant discarded. An aliquot for cell count was taken 
prior to wash to remove debris. As an example of a point to be considered in preparation, as 
well as interpretation of the results, the amount of debris must be taken into account, as this 
affects adjustment of the final concentration for running on CyTOF. Cells were left pelleted 
until ready to run on CyTOF. The cell concentration was adjusted to 106/mL with deionized 
water. Immediately prior to CyTOF data acquisition, the pellet was resuspended in a volume 
of EQ Four element calibration beads (mixed well and diluted 1:10) needed to bring cells to 
a final concentration of 106/mL; cells were then filtered into cell strainer cap tubes.
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Results and discussion
Comparison of mass cytometry and flow cytometry
Flow Cytometry is a laser-based technology employed in cell counting, cell sorting, 
biomarker detection, and protein engineering, by suspending cells in a stream of fluid and 
passing them by an electronic detection apparatus. Mass cytometry is similar to flow 
cytometry in that antibodies are labelled with heavy metal ion tags rather than 
fluorochromes [2, 3, 15]. Mass cytometry can be applied extensively for use in a variety of 
experiments and analyses for clinical research and drug development. However, mass 
cytometers require qualified personnel for operation and maintenance of the instrument in 
order to ensure high-quality results. Although the protocols for sample preparation and 
staining are similar to those used in flow cytometry assays, further optimizations are 
required to ensure that the reagents’ stability and reproducibility are maintained. Figure 1 
shows a comparison between CyTOF and flow cytometry using the same sample and 
comparing some of the most used markers in immune monitoring. Both the profile and the 
proportion of the different immune populations are similar using either method; the choice 
of using one over the other depends on the aim pursued. While flow cytometry has proven to 
be fairly reproducible and the reagent in general well controlled, it is very limited as to deep 
profiling and discovery of smaller, rare, or unique cell subsets. Table 1 provides a detailed 
comparison side by side of the two methods and the pros and cons for each method. High 
throughput in quantitative bioanalysis applies to steps such as assay development, sample 
collection and sorting, sample preparation, sample analysis, and data processing and 
reporting. The CYTOF2 instrument can measure ~500 cells/s, the upgrade system or Helios 
can measure up to 1000 cells/s, and flow cytometry ~80,000 cells/s [15].
Sources of technical variability in quantitative mass cytometry
In order to design a robust quantitative mass cytometry study, we need to be aware of the 
inherent heterogeneity of the biological samples as well as the technical variability of the 
mass cytometry instrument. The storage conditions between sampling and analysis must be 
controlled to ensure that the samples do not degrade. Given that it is preferable to run 
samples within 1 h, such operator-related delays are likely to be very costly and wasteful. 
Other sources of variabilities involved sample processing, contamination, sample stability, 
instrument stability, and data processing. Also sample collection is important for any 
quantitative analysis to ensure that a representative and sufficiently homogeneous sample is 
taken for analysis. Correct data processing is a fundamental step in generating good quality 
quantitative data. Salts in samples will reduce the sensitivity but this can be minimized when 
cells are washed with water before analysis. If particular attention is not paid to all of the 
above, sample integrity may be sacrificed and the analysis data affected, compromised, or 
rendered invalid. Below, we will address some of these issues and offer suggestions to 
minimize labor, time, and effort, and reduce overall errors, through use of automated 
equipment.
Shipping of labelled samples for CyTOF analysis
Collection, temperature-controlled stability, packaging, and safe, timely delivery of labelled 
samples for CyTOF analysis are crucial throughout. Results from overnight shipment of 
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stained samples showed when samples are washed with 2% PFA in PBS pre-shipment, 
processing resulted in 79% cell recoveries [16], while for samples washed with 2% PFA in 
deionized water pre-shipment processing resulted in 48% cell recoveries [16]. This 
suggested that cell loss is greater if cells are washed with deionized water prior to shipment. 
Also, we found out that the cell loss is greater when shipping lower numbers of cells [16]. It 
was suggested that three critical factors in determining cell recovery from shipped samples 
are (1) cells should be washed and fixed in PBS buffer prior to shipping, (2) cells should be 
shipped in bulk and serial dilutions prepared at analysis site, if possible, (3) samples should 
remain cold during shipping and sample preparation [16].
Storage of labelled samples with stable heavy metal isotopes for CyTOF analysis
Storing samples that are already labelled with stable heavy metal isotope and ready for 
acquisition is an important issue when the CyTOF system is not available within a few days 
of sample staining. Recently, we reported that storage of labelled CyTOF samples in water 
can affect some of the markers [15]. In this article, we have studied the effect of storage of 
the samples over 10 days. Figure 2 represents a comparison between acquiring the same 
sample on the same day and storing it to be acquired 10 days later. Storage of labelled 
CyTOF samples: PBMC were isolated from a healthy donor’s peripheral blood and stained 
for CyTOF. The sample was divided in four equal aliquots; one aliquot of the sample was 
acquired the same day on the CyTOF. The three remaining aliquots were centrifuged and re-
suspended in PBS + 10% DMSO and stored at −20 °C, or in PBS and stored at either −20 or 
4 °C. After 10 days, the samples were brought to room temperature, washed with deionized 
water and acquired. The figure shows a comparison of some of the biomarkers used for all 
the four conditions; there is no significant difference between them. This shows that the 
samples can be stored either frozen or at 4 °C and acquired within 10 days without affecting 
the quality of the data.
Stability of staining in deionized water
Another important consideration is the sample stability in deionized water. Sample 
preparation for CyTOF requires that the last step consist of washing the sample in deionized 
water and resuspending it in deionized water before acquisition. Due to the limited number 
of events that can be acquired on CyTOF per minute, several consecutive runs of the same 
sample are often necessary in order to collect enough events for a meaningful analysis, 
especially for rare cell populations. viSNE is a new high-dimensional cytometry analysis 
tool based on the t-distributed stochastic neighbor embedding (t-SNE) algorithm [17]. Figure 
3 is a viSNE comparison of the staining pattern of different markers over time when stored 
in deionized water. CyTOF antibodies are rather unstable in deionized water: the biomarker 
pattern is significantly disrupted after 1 h and even more after 4 h. Most cell markers seem 
to fade; the biggest loss involves B and NK cells. This suggests that, once the cells are 
suspended in deionized water, the analysis should be performed expeditiously, preferably 
within the first hour. The damage can be minimized if the cells are resuspended in PBS 
rather than deionized water while waiting for data acquisition (Fig. 3). For terms longer than 
10 days, cell storage in DMSO is preferred.
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Discriminating live and dead cells in CyTOF
Discriminating and excluding dead cells decreases non-specific binding of antibodies to the 
cells and provides better data. Many viability dyes are currently used in flow cytometry, such 
as propidium iodide. There was a lack of such products for CyTOF until several years ago 
when cisplatin (195Pt or 198Pt) was adopted to stain dead cells for CyTOF. However, some 
considerations should be taken while using cisplatin in the protocol; for example, cell 
degradation and/or death occur at higher concentrations or longer incubation times. The 
proper concentration level (50 M) is critical to achieve the best results. When the cells are 
incubated for a very short time (1 min) with cisplatin at this concentration, there is 3.7% 
dead cells; this result is comparable to viability measurements produced by flow cytometry 
after staining with propidium iodide (3.85% dead cells) (Fig. 4). Another factor is that 
cisplatin should be fresh. Its chemical properties are altered by lengthy storage at room 
temperature or repeated freeze-thaw cycles. Such conditions cause the reagent to display 
increased potential for non-specific binding, which in turn may interfere with discrimination 
between live and dead cells.
Titration of antibodies for CyTOF analysis
This is done in order to optimize the separation of positive and negative populations. If the 
antibody conjugate is bright and there are plenty of cells in the target population, this may 
not be as much of an issue. But for many surface and intracellular markers, the positive peak 
will not be clearly distinct from the negative peak. Titrating antibodies can significantly 
improve this. Not all traditional antibodies work well in all fixation realization buffer 
conditions. It is critical to have multiple populations during titration; the ideal is to find the 
best separation between known positive and negative reference samples. It is also important 
to titrate the antibodies in the conditions matching those of the particular study: fresh, 
frozen, or fixed. By cleaning data and gating out the dead cells, debris, and doublets, the 
populations look well defined and easy to identify. Figure 5 is freshly isolated PBMCs from 
peripheral blood which were labelled with different concentrations of CyTOF antibodies 
against 40 different markers. The master mix of the antibody cocktail started at 4 µg/ml of 
each antibody. The PBMC sample containing 12 × 106 cells was split equally in 6 wells of a 
96-well titer plate. Each well received a dilution of the antibody cocktail (4, 2, 1, 0.5, 0.25 
µg/ml) or no antibodies (0); the staining volume was kept constant (100 µl). After 20 min the 
cells were washed, fixed and labelled with 191 and 193 Ir for DNA, 1.0 µl of 125 µM Ir-
intercalator overnight at 4 °C. The samples were acquired on a CyTOF and analyzed using 
Cytobank software. The results shown in the figure were obtained after first gating on 
singlets, then live CD45 positive cells, and finally plotting some of the PBMC population 
markers using two-dimensional density plots. The best resolutions of population clusters and 
signals were generally seen with antibody concentrations of 1 µg/ml or lower. At high 
antibody concentrations, the signals from different channels showed more noise and spilled 
into other channels, generating false positive and double (multiple) stained populations.
Automated sample preparation
Sample preparation is an important and critical step in the entire workflow [14, 18] and 
represents the largest bottleneck in the modern research lab. Most sample preparation 
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techniques for CyTOF are still non-automated and require substantial labor-intensive and 
time-consuming operations, which leads to unwanted levels of variation in bioanalytical 
measurements. Because of the effect of sample preparation on analysis time and error 
generation, automation of the procedure can minimize the time, labor, and error-producing 
aspects of a typical bioanalytical method. Automated sample preparation methods 
consistently, and rapidly, process all samples in the same way. Our robotic platform uses 
automated methods which have been validated on the Biomek FXp [19–21] and is capable 
of batch processing a range of between 24 and 96 coded samples. By combining barcoding 
and this higher level of throughput, standardization, accuracy, precision, flexibility, and 
operational logistics are significantly improved.
Important considerations for sample preparation
If particular attention is not paid to all of sources of error such as sample processing, 
contamination, sample stability, instrument stability, storage conditions, and correct data 
processing, the sample integrity may be sacrificed and the analysis data affected, 
compromised, or rendered invalid [14, 18]. Sample preparation and the number of cells per 
sample are critical factors in determining cell recovery from shipped samples. Recovery 
rates for most of the current protocols are limited to 50% of cells; much of this is due to the 
number of washing steps required [22]. Cell loss is greater if cells are washed with deionized 
water prior to shipment [16]. Cell loss is greater when shipping lower numbers of cells. 
Strategies for shipping staining samples: wash and fix cells in PBS buffer prior to shipping; 
ship cells in bulk and prepare serial dilutions at analysis site if possible; ensure that samples 
remain cold during shipping. The automated robotic platform is essential for sample 
preparation and provides more reliable results [23].
Mass cytometry signal drift during the analysis
Suppression ionization, resulting from easily ionized elements in the reagent/sample mix, is 
a significant source of interference; it can harm both sensitivity and reproducibility of 
quantitative data. Signal drift could result from the following:
• Matrix effects attributed to the space charge effect in the ion beam in the ICP-
MS.
• Matrix effects originating in the plasma where the easily ionized matrix elements 
increase the electron density in the central channel of the plasma, thus decreasing 
the analyte ion signal.
• Sample settling during long run, gently vortex every 10 min
• Stability in water, avoid leaving the sample in water for more than 1 h
Space charge effects exist in an ion beam with excess positive charge, where the charges on 
the ions repel each other to form space-charge-limited flow. There are three important effects 
caused by the space charge force in such an ion beam: depression of the potential in the 
beam; beam spreading; and limitation to the maximum current. Heavier elements with 
higher kinetic energies have higher transmission through the ion optics under the space-
charge-limited flow, while lighter elements with lower kinetic energies are more susceptible 
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to space charge repulsion and thus will deviate from the center of the ion beam. Hence, light 
ions are transmitted less efficiently than heavy ions.
Matrix effects are characterized as a function of analyte ion mass, matrix ion mass, matrix 
concentration, lens voltages, and nebulizer gas flow rate and can be divided into two types: 
signal drift due to the deposition of solids on the sampling apertures and/or signal 
suppression or enhancement by the presence of the dissolved salts. Polyatomic interferences 
result from the combination of two or more isotopes from different elements, which usually 
occur in the plasma. The elements that form the polyatomic interferences usually result from 
the sample matrix, sample diluent, and argon itself. The dissolved salts, especially refractory 
oxides, tend to deposit on the cool tip of the sampling cone. The clogging of the orifices 
reduces the ion flow into the ICP-MS, lowers the pressure in the first stage of ICP-MS, and 
enhances the level of metal oxide ions. Because the extent of the clogging increases over 
time, the signal drifts down. Perhaps the most satisfactory method to eliminate matrix effects 
is to remove the matrix elements altogether. Suggestions for minimizing matrix interferences 
in ICP-MS due to high concentrations of concomitant elements present in the solutions are 
as follows:
• The degree of the matrix effect is strongly dependent on the nebulizer flow-rate 
and tends to be less severe at low nebulizer flow-rates than at high nebulizer 
flow-rates.
• Minimize acid interferences for elements of interest
• Internal calibration is also included to correct for instrumental drift, using 
multiple internal standard elements so that an internal standard could be used to 
correct for matrix effects on signals from analyte ions with similar masses. This 
correction works best when a known amount of the internal standard is added to 
the sample, and if the element being added is near the same mass as the analyte 
element.
• Use the standard additions method for analyte element to correct for sensitivity 
interferences.
• Use the isotope dilution method to avoid all sensitivity interferences and sample 
recovery issues during processing. Dilution is necessary for ICP-MS analysis of 
biological samples because large amounts of proteins and salts can cause an 
irreversible reduction of the analyte signal intensity due to clogging of the 
nebulizer, torch, sampling, and skimmer orifices. Besides preventing clogging 
and reducing the matrix effect, dilution is also necessary to improve the accuracy 
of internal calibration.
Given that CyTOF has a cell transmission rate of 30% when 0.5 M cells inject at 45 µl per 
min, a large quantity of cells is required to achieve meaningful data. This can be a severe 
constraint when dealing with limited clinical samples. This low recovery makes it a 
challenge to measure rare populations and may produce inaccurate quantitation results for 
those populations. Also, where flow cytometry can process about 80,000 events/s, CyTOF 
can process about 1000 events/s. This limited capacity may develop bias when a larger data 
set is analyzed, due to drift of the signal intensity over time. Also, this bias further constrains 
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the high throughput capability of CyTOF. Cell fixation and permeabilization are required for 
the present barcoding method; however, some surface markers, such as CCR6, CXCR3, 
CCR7, CD45RO, CD127, CD11b, and CD56, show poor performance upon barcoding.
Our modified barcoding protocol addresses this by staining the samples for these fixation-
sensitive markers prior to starting the barcoding procedure. When possible, use of antibodies 
that can recognize their epitopes after fixation is another solution. It is important to label 
some markers (e.g., CXCR3, CCR4, CXCR5, CCR6, CCR7, CD45RO, CD127) before 
barcoding, so as to avoid potential damage during preparation.
Washing steps are important to minimize cross talk between barcoding and to remove the 
potential interfering elements. Once barcoded, the samples must be thoroughly mixed; it is 
advised to gently vortex the sample or pipette up and down several times to ensure complete 
mixing. Incomplete mixing is manifested by populations that have irregular shapes and 
broader distributions. Both yield and separation are improved by gating out debris and 
doublets according to DNA intercalator staining prior to application of the debarcoding 
software.
Conclusions
In this article, we have compared flow cytometry and CyTOF with reference to a wide 
variety of parameters, with an eye toward their relative strengths and weaknesses. We 
address points to be considered during sample preparation for barcoding that allow for a 
detailed examination of the variability of quantitative mass cytometry measurements. Also, 
several considerations such as cisplatin concentration, sample stability, and storage were 
presented to optimize our sample preparation protocol for barcoding CyTOF in support of 
clinical research. Manual sample preparation can be inconsistent and time-consuming. On 
the other hand, automated sample preparation for barcoding has been very useful in that the 
steps are performed the same way every time. Multiplexing large numbers of samples 
produces consistent results in terms of standardization, accuracy, and operational logistics by 
eliminating variations such as sample-specific staining and in data collection; additionally, 
there is a significant reduction in waste created by preparation errors.
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Abbreviations
CyTOF Cytometry by Time-Of-Flight
FB Fixation buffer
ICP-MS Inductively coupled plasma-mass spectrometry
MCB Mass-tag cellular barcoding
PBMC Peripheral blood mononuclear cell
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PMA Phorbol 12-myristate 13-acetate, also known as 12-O-
tetradecanoylphorbol-13-acetate (TPA)
SB Maxpar Cell Staining Buffer
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Fig. 1. 
Comparison between CyTOF and flow cytometry data: PBMCs (peripheral blood 
mononuclear cells) were prepared from cryopreserved peripheral blood of a healthy donor 
and split in two tubes, one for flow cytometry staining and one for CyTOF staining. After 
gating on live cells, different markers are compared between flow cytometry (upper panel) 
and CyTOF (lower panel)
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Fig. 2. 
Illustration of a comparison between acquiring the same sample on the same day and storing 
it to be acquired 10 days later
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Fig. 3. 
Representative antibody surface-staining results after the sample has been stored in 
deionized water for 0, 1, 2, and 4 h, or resuspended in PBS for 4 h
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Fig. 4. 
Use of cis195Pt as a viability dye for CyTOF: a Freshly isolated PBMCs were incubated 
with different doses of cis195Pt for 1 or 10 min, then they were washed and labelled with 
DNA intercalator and washed again before injection to CyTOF. b the same PBMC were 
labelled with propidium iodide and analyzed on a flow cytometer
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Fig. 5. 
Freshly isolated PBMCs from peripheral blood were labelled with different concentrations 
of antibody cocktail (4, 2, 1, 0.5, 0.25 µg/ml) or no antibodies (0) against 40 different 
markers
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Table 1
Comparison between mass cytometry and flow cytometry
Technology Mass Cytometry Flow Cytometry
Measurement Stable mass isotope probes Fluorescent probes
Application Biomarkers, immunophenotyping, function, 
pharmacodynamic (PD)
Biomarkers, immunophenotyping, function, PD
Workflow • Isolate cells
• Immunostain
• Determine protein expression or 
modifications by amount of metal 
ions observed
• Isolate cells
• Immunostain
• Compensate fluorophores
• Determine protein expression or 
modifications by intensity of 
fluorescence observed
Multiplex Capacity ~40 ~20
It can be up to120 if more isotopes become 
available
Sample Barcoding Yes Yes
Detection limit ~300 molecules/single cell 100–300 molecules/single cell (varies by fluorophor, 
without compensation)
Data analysis Complexity Moderate-high Low-high (Deconvolution for high- parameter flow)
Information Content / Sample High Moderate
Single-cell resolution Yes Yes
Throughput ~500 cells/s ~80,000 cells / s
Analytical efficiency ~30% ~90%
Live cell Analysis/Cell Sorting Not possible Possible
Cost/Sample ~$150 ~$5
Instrument cost ~$650,000 ~$500,000
Vendor(s) Fluidigm Multiple
Impact Multiplex Capacity, Specificity, Small Sample Size Sensitivity, Downstream Live Cell Analysis
Maintenance 1 h daily 15 min daily
4 h weekly 30 min weekly
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